XORTX Therapeutics Inc.

TSXV:XRTX Stock Report

Market Cap: CA$9.9m

XORTX Therapeutics Management

Management criteria checks 2/4

XORTX Therapeutics' CEO is Allen Davidoff, appointed in Jan 2018, has a tenure of 6.33 years. total yearly compensation is $422.09K, comprised of 76.2% salary and 23.8% bonuses, including company stock and options. directly owns 2.34% of the company’s shares, worth CA$231.05K. The average tenure of the management team and the board of directors is 2.4 years and 3.6 years respectively.

Key information

Allen Davidoff

Chief executive officer

US$422.1k

Total compensation

CEO salary percentage76.2%
CEO tenure6.3yrs
CEO ownership2.3%
Management average tenure2.4yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation

Aug 23
Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation

XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business

Apr 01
XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business

We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow

Dec 16
We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow

Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth

Sep 01
Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth

CEO Compensation Analysis

How has Allen Davidoff's remuneration changed compared to XORTX Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$2m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$7m

Mar 31 2023n/an/a

-US$6m

Dec 31 2022US$422kUS$322k

-US$8m

Sep 30 2022n/an/a

US$1m

Jun 30 2022n/an/a

-US$3m

Mar 31 2022n/an/a

-US$2m

Jan 01 2022n/an/a

-US$2m

Sep 30 2021n/an/a

-US$9m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$3m

Dec 31 2020US$204kUS$154k

-US$1m

Sep 30 2020n/an/a

-US$767k

Jun 30 2020n/an/a

-US$536k

Mar 31 2020n/an/a

-US$362k

Dec 31 2019US$161kUS$148k

-US$485k

Sep 30 2019n/an/a

-US$444k

Jun 30 2019n/an/a

-US$582k

Mar 31 2019n/an/a

-US$660k

Dec 31 2018US$194kUS$141k

-US$3m

Compensation vs Market: Allen's total compensation ($USD422.09K) is above average for companies of similar size in the Canadian market ($USD175.48K).

Compensation vs Earnings: Allen's compensation has increased whilst the company is unprofitable.

CEO

Allen Davidoff (63 yo)

6.3yrs

Tenure

US$422,086

Compensation

Dr. Allen Warren Davidoff, Ph.D. is Founder of XORTX Therapeutics Inc. (formerly known as XORTX Pharma Corp.) and has been its Chief Executive Officer and President since January 9, 2018. Dr. Davidoff serv...

Leadership Team

NamePositionTenureCompensationOwnership
Allen Davidoff
Founder6.3yrsUS$422.09k2.34%
$ 231.1k
James Fairbairn
Interim Chief Financial Officerless than a yearUS$43.21k0.24%
$ 23.6k
Stephen Haworth
Chief Medical Officer2.8yrsUS$254.49k0%
$ 0
Stacy Evans
Chief Business Officer1.5yrsUS$85.41kno data
Nick Rigopoulos
Director of Communicationsno datano datano data
David Sans
Director of Corporate Development3.8yrsno datano data
David MacDonald
Consultant of Clinical Operations2yrsno datano data
Charlotte May
Corporate Secretaryno datano data0%
$ 0

2.4yrs

Average Tenure

59.5yo

Average Age

Experienced Management: XRTX's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Allen Davidoff
Founder6.3yrsUS$422.09k2.34%
$ 231.1k
Paul Van Damme
Independent Director6.3yrsUS$39.68k0.25%
$ 24.2k
Anthony Giovinazzo
Independent Chair of the Board1.9yrsUS$197.78k0.33%
$ 32.7k
Richard Johnson
Member of Clinical Advisory Boardno datano datano data
William Farley
Independent Director3yrsUS$37.02kno data
Raymond Pratt
Independent Director2.4yrsUS$36.14kno data
Henk E. D. ter Keurs
Member of Scientific Advisory Boardno datano datano data
Federico Maese
Member of Clinical Advisory Board5.6yrsno datano data
Patrick Treanor
Directorless than a yearno datano data
Petter Bjornstad
Member of Clinical Advisory Board5.6yrsno datano data
Anjay Rastogi
Member of the Clinical Advisory Board4.2yrsno datano data
Charles Edelstein
Member of the Advisory Board2.8yrsno datano data

3.6yrs

Average Tenure

67yo

Average Age

Experienced Board: XRTX's board of directors are considered experienced (3.6 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.